A Phase 1, Open-label, 2-period Fixed-sequence Study to Evaluate the Effect of Multiple Doses of SHP620 (Maribavir) on the Pharmacokinetics of Digoxin and Dextromethorphan in Healthy Adult Subjects

Trial Profile

A Phase 1, Open-label, 2-period Fixed-sequence Study to Evaluate the Effect of Multiple Doses of SHP620 (Maribavir) on the Pharmacokinetics of Digoxin and Dextromethorphan in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Maribavir (Primary) ; Dextromethorphan; Digoxin
  • Indications Cytomegalovirus infections
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 20 Sep 2016 Status changed from recruiting to completed.
    • 24 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 21 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top